AzTrials
AzTrials

PainNCT06352021

The Effect of Distraction With a Kaleidoscope on the Level of Perceived Pain During Blood Sampling in Children

A study testing kaleidoscope in people with Pain, run by İlknur KAHRİMAN at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This experimental study aimed to determine the effect of distracting children with a kaleidoscope during blood sampling on their perception of pain during the procedure and to increase and improve the quality of evidence for the effectiveness of these methods across different populations and cultures. Read more about this study

Who is it for?
Ages 7 to 12 yearsHealthy volunteers can take part
Conditions the study is for
Pain
What is being tested?
kaleidoscope
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
60 participants
Where
1 siteTurkey (Türkiye)
Study dates
30 May 2019to 30 Jun 2019
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 7 to 12 years
  • All sexes
  • Healthy volunteers accepted
  • Child

Who may be able to join

  • were being 7-12 years of age
  • not having an auditory or visual disability
  • not taking analgesics in the last eight hours
  • not having any pain caused by other reasons before the procedure
  • having vascular access and blood sampling interventions

Who cannot join

  • having physical or mental disability
  • having any nerve damage

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Karadeniz Technical University Health Application and Research Center Farabi Hospital

    Trabzon, 61080

Other trials in Turkey (Türkiye)

About this study

This experimental study aimed to determine the effect of distracting children with a kaleidoscope during blood sampling on their perception of pain during the procedure and to increase and improve the quality of evidence for the effectiveness of these methods across different populations and cultures.

Hypothesis 0 (H0): There is no difference between the pain scores of the kaleidoscope group and the control group during blood sampling.

Hypothesis 1 (H1): There is a difference between the pain scores of the kaleidoscope group and the control group during blood sampling.

Read the detailed description

A pain-free life is the right of every child. Eliminating pain and improving the quality of life of children is one of the main goals of nursing care. Pediatric nurses should choose the appropriate assessment tool for the child's age and developmental characteristics and diagnose pain correctly. For this purpose, nurses can use appropriate distraction methods. Since the nurse is the healthcare worker who is with the child and family the most throughout the day, s/he should closely monitor and evaluate the child's pain and inform the child and family about the principles of pain control. Many hospitals in Türkiye generally do not use any non-pharmacologic methods to reduce procedural pain. Given that distraction techniques are inexpensive and easy to use, and that reducing children's pain may reduce negative feelings towards future procedures, it is important to examine the effectiveness of such methods. In our study, a kaleidoscope, one of the methods of distraction to reduce pain during blood sampling in children, was used. A kaleidoscope is a game tool that helps distract the child's attention from procedural pain and shows the external image by reproducing it when viewed through it. This experimental study aimed to determine the effect of distracting children with a kaleidoscope during blood sampling on their perception of pain during the procedure and to increase and improve the quality of evidence for the effectiveness of these methods across different populations and cultures.

Conditions
Pain
Being tested
kaleidoscope
Keywords
Blood collection, Distraction, Non-pharmacological treatment, Pain, Schoolchild
Medical subject headings
Pain

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • kaleidoscopeDevice

    The children in the kaleidoscope group were shown the kaleidoscope by the researcher five minutes before the blood sampling, and they were encouraged to look at the kaleidoscope during the procedure and describe the patterns they saw. All children in the Kaleidoscope group agreed to participate in the study. All children in the kaleidoscope group were asked to look at the kaleidoscope just before the tourniquet was placed on their arms before the blood sampling procedure and to describe the patterns, they saw in it by turning it slowly during the procedure.

Study groups in NCT06352021
Study groupRoleWhat they receive
kaleidoscope groupExperimentalThe children in the kaleidoscope group were shown the kaleidoscope by the researcher five minutes before the blood sampling, and they were encouraged to look at the kaleidoscope during the procedure and describe the patterns they saw.
Receives: Device: kaleidoscope
control groupNo interventionThis group underwent routine blood sampling procedures and did not receive any intervention to reduce their pain.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. The Wong-Baker Pain Scale

    The scale was developed by Wong and Baker (1981) to assess pain between the ages of 3-18 years. It has been reported in the literature that it accurately measures children's pain. The scale has numerical values according to each facial expression. The lowest and the highest values are 0 and 5. As the score on the scale increases, sensitivity to pain decreases, and as the score decreases, sensitivity increases.

    Measured: 5 minutes

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted8 Apr 2024
  2. Study start30 May 2019
  3. Primary completion30 Jun 2019
  4. Study completion30 Jun 2019

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
60 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06352021
Sponsor's protocol ID
KAHRİMAN İlknur
Status last verified
Apr 2024
First submitted
17 Mar 2024
Last updated
8 Apr 2024
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing kaleidoscope in people with Pain, run by İlknur KAHRİMAN at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 8 Apr 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

The Wong-Baker Pain Scale (time frame: 5 minutes). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Apr 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in